• Fri, February 1, 2013

by: WOPRAI

China Logistics Group Inc (OTC:CHLO), Up By 16.67% ($0.01) From $0.060 After BUYINS.NET Report Predicted Stock Would Go Up Due

by: WOPRAI

Greenway Medical Technologies Inc (NYSE:GWAY), Up By 10.03% ($1.48) After BUYINS.NET SqueezeTrigger Report Released on Thursday

by: WOPRAI

Fortinet Inc (NASDAQ:FTNT), Up By 6.67% ($1.52) After BUYINS.NET SqueezeTrigger Report Released on Thursday, January 31st 2013

by: WOPRAI

Copart Inc (NASDAQ:CPRT), Up By 6.66% ($2.34) After BUYINS.NET SqueezeTrigger Report Released on Thursday, January 31st 2013 at

by: WOPRAI

Regis Corp (NYSE:RGS), Up By 6.12% ($1.03) After BUYINS.NET SqueezeTrigger Report Released on Thursday, January 31st 2013 at a

by: WOPRAI

Cardiff International Inc (OTC:CDIF), Up By 47.06% ($0.01) From $0.017 After BUYINS.NET Report Predicted Stock Would Go Up Due

by: WOPRAI

BofI Holding Inc (NASDAQ:BOFI), Up By 7.65% ($2.30) From $30.050 After BUYINS.NET Report Predicted Strength Before Earnings

by: WOPRAI

Agria Corp (NYSE:GRO), Down By 7.41% ($0.06) From $0.810 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish C

by: WOPRAI

Manulife Financial Corp (NYSE:MFC), Down By 7.67% ($1.12) From $14.600 After BUYINS.NET Report Predicted Weakness Before Earnin

by: WOPRAI

Diadem Resources Ltd (NYSE:DRL), Down By 6.94% ($0.05) From $0.720 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

Generex Biotechnology Corp (NASDAQ:GNBT), Down By 13.33% ($0.01) From $0.045 After BUYINS.NET Report Predicted Stock Would Go D

by: WOPRAI

PSE SqueezeTrigger Price is $25.58. There is $5,917,944 That Short Sellers Still Need To Cover.

by: WOPRAI

PKE SqueezeTrigger Price is $26.42. There is $13,814,064 That Short Sellers Still Need To Cover.

by: WOPRAI

MAGS SqueezeTrigger Price is $4.40. There is $210,456 That Short Sellers Still Need To Cover.

by: WOPRAI

BMSN, KEYP, Removed From Naked Short Lists Today

by: WOPRAI

AAXJ, NRBAY, Added To Naked Short Lists Today

by: WOPRAI

Telefon AB L M Ericsson (NASDAQ:ERIC), Up By 10.31% ($1.11) After BUYINS.NET SqueezeTrigger Report Released on Thursday, Januar

by: WOPRAI

NVEC, HJN, JBK Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

MWR, GMA, HJJ, FCFC, CGEN, CAAS Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

FXB, GKK, ACTS, ABIO, GENT, MOSY Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

INUV, TEAR, KUTV, AMCN, GLDD, DLIA Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

SD, GSC, ITUB Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

MNOV, DVR, CLR, YGE, NYF, RJN Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

MDVN, GOL, SXL, LLNW, GSP, VPFG Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CVCO, AEF, NATR, ATR, MKTX, GRH Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CLMS, PPS Expected To Be Down After Next Earnings Releases

by: WOPRAI

NANO, MDU, AP, GGP, AXS, BRE Expected To Be Down After Next Earnings Releases

by: WOPRAI

BDX, TE Expected To Be Down Before Next Earnings Releases

by: WOPRAI

FBN, CLI, MPW, VICL, MOC, BP Expected To Be Down Before Next Earnings Releases

by: WOPRAI

CBR, JAKK, VIAS, OFC, MTG, RSTI Expected To Be Down Before Next Earnings Releases

by: WOPRAI

RBC, GILD, ACLS, LMNX, SWI, SYA Expected To Be Up After Next Earnings Releases

by: WOPRAI

AMED, RRGB, CX, JNY Expected To Be Up Before Next Earnings Releases

by: WOPRAI

Rufus Hone Maintained (BX) at Buy with Increased Target to $21 on, Feb 1st, 2013

by: WOPRAI

Raimo Lenschow Initiated (WDAY) at Hold and Held Target at $58 on, Feb 1st, 2013

by: WOPRAI

Christian Wetherbee Downgraded (UPS) to Hold and Decreased Target to $83 on, Feb 1st, 2013

by: WOPRAI

Tycho Peterson Upgraded (TMO) to Buy and Increased Target to $80 on, Feb 1st, 2013

by: WOPRAI

Dan Brennan Maintained (TMO) at Strong Buy with Increased Target to $82 on, Feb 1st, 2013

by: WOPRAI

Martin Auster Maintained (BMRN) at Strong Buy with Increased Target to $67 on, Feb 1st, 2013

by: WOPRAI

Tom Roderick Maintained (BCOV) at Strong Buy with Decreased Target to $20 on, Feb 1st, 2013

by: WOPRAI

Andrew Kligerman Maintained (CB) at Buy with Increased Target to $87 on, Feb 1st, 2013

by: WOPRAI

Brian Meredith Maintained (CB) at Strong Buy with Increased Target to $88 on, Feb 1st, 2013

by: WOPRAI

Bryan Spillane Downgraded (STZ) to Hold and Decreased Target to $33 on, Feb 1st, 2013

by: WOPRAI

Bret Jordan Maintained (TEN) at Strong Buy with Increased Target to $42 on, Feb 1st, 2013

by: WOPRAI

Wayne Hood Maintained (TSCO) at Hold with Increased Target to $57 on, Feb 1st, 2013

by: WOPRAI

Jason Gerberry Downgraded (ALKS) to Hold and Increased Target to $24 on, Feb 1st, 2013

by: WOPRAI

Sam Darkatsh Downgraded (WHR) to Buy and Increased Target to $125 on, Feb 1st, 2013

by: WOPRAI

David Rochester Maintained (CFR) at Hold with Increased Target to $58 on, Feb 1st, 2013

by: WOPRAI

Noah Kaye Downgraded (AMRC) to Hold on, Feb 1st, 2013

Martin Auster Maintained (BMRN) at Strong Buy with Increased Target to $67 on, Feb 1st, 2013

Martin Auster of UBS, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $53 to $67 on, Feb 1st, 2013.

Martin has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Martin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Martin

  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $54 on, Tuesday, November 6th, 2012
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $56 on, Monday, November 5th, 2012

Like: 👍